首页 | 本学科首页   官方微博 | 高级检索  
检索        

TACE联合经皮无水乙醇注射在原发性肝癌治疗中的价值
引用本文:郭晓华,何建荣,金红来,林开勤,胡晓刚.TACE联合经皮无水乙醇注射在原发性肝癌治疗中的价值[J].医学影像学杂志,2009,19(5):555-557.
作者姓名:郭晓华  何建荣  金红来  林开勤  胡晓刚
作者单位:浙江省金华市中心医院介入治疗室,浙江,金华,321000
摘    要:目的:评价肝动脉灌注化疗栓塞(TACE)、经皮无水乙醇注射联合治疗原发性肝癌的价值。方法:应用TACE单独治疗原发性肝癌64例,TACE与PEI联合治疗原发性肝癌21例。术后对比12个月,18个月,24个月生存期,评价TACE与PEI联合治疗的价值。结果:TACE+PEI组肿瘤缩小有效率为85.71%,TACE组肿瘤缩小有效率68.75%。TACE+PEI组1、2.3年生存率分别为97.2%、72.1%、39.6%。TACE组患者1、2、3年生存率分别为83.6%、34.3%、16.2%。结论:TACE联合PEI可以提高原发性肝癌的疗效。

关 键 词:原发性肝癌  肝动脉关注化疗栓塞  经皮注射无水乙醇

Transcatheter hepatic arterial chemoembolization combined percutaneous ethanol injection in treating primary hepatic carcinoma
GUO Xiao-hua,HE Jianrong,JIN Hong-lai,LIN Kai-qin,HU Xiao-gang.Transcatheter hepatic arterial chemoembolization combined percutaneous ethanol injection in treating primary hepatic carcinoma[J].Journal of Medical Imaging,2009,19(5):555-557.
Authors:GUO Xiao-hua  HE Jianrong  JIN Hong-lai  LIN Kai-qin  HU Xiao-gang
Institution:( Interventional Therapy Koom Jinhua Municipal Central Hospital, Jin Hua, Zhejang 321000, P. R. China)
Abstract:Objective:To evaluate clinical efficacy of the transcatheter hepatic arterial chemoenbolization (TACE)combined pereutaneous ethanol injection(PEI)in treating primary hepatic carcinoma. Methods: 85 cases with primary hepatic carcinoma were divided into TACE + PEI group and TACE group. 21 cases underwent TACE combined PEI treatment, 64 cases underwent TACE treatment. Results: The effective rate of TACE+ PEI group is 85.71%, the one of TACE group is 68.75%. The lyear, 2 year, 3 year survival rates of the TACE + PH group and TACE group were 97.2 %, 72. 1%, 39.6 % and 83.6 %, 34.3 %, 16.2 % respectively. Conclusion: TACE combined PEI is a better treatment of primary hepatic carcinoma.
Keywords:Primary hepatic carcinoma  Transcatheter hepatic arterial ehemoembolization(TACE)  Pereutaneous ethanol injection (PEI)
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号